Commentary published on the FDA panel discussion about SSRI use in pregnancy

Professor Per Damkier (the outgoing Chair of the ENTIS Scientific Committee) and Dr Matitiahu Berkovitch (President of ENTIS) have published a commentary in the British Journal of Obstetrics and Gynaecology discussing the FDA panel discussion (broadcast 21 July 2025) about the safety of selective serotonin reuptake inhibitors (SSRI) in pregnancy.

Photo by Sam Szuchan on Unsplash